Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Neeraj Songara։ TRAGS – When Alpha-Gal Meets ABO Compatibility
Neeraj Songara/LinkedIn
Sep 12, 2026, 09:13

Neeraj Songara։ TRAGS – When Alpha-Gal Meets ABO Compatibility

Neeraj Songara, Resident Doctor at Dr S.N. Medical College Jodhpur, shared a post on LinkedIn about a recent article by Richard M. Kaufman et al., published in JAMA Internal Medicine, adding:

“TRAGS: When Alpha-Gal Meets ABO Compatibility

A new transfusion reaction entity is challenging how we think about ‘compatible’ blood components.

TRAGS – Transfusion-Related Alpha-Gal Syndrome – refers to a potentially severe allergic transfusion reaction associated with alpha-gal sensitization and exposure to Group B antigen, particularly when Group O patients receive Group B or AB plasma-containing components.

Alpha-gal syndrome (AGS) is an IgE-mediated allergy against galactose-α-1,3-galactose (α-Gal), commonly associated with tick exposure.

The intriguing part is that the B blood group antigen contains an α-Gal–like terminal carbohydrate structure.

In a sensitized individual, anti-α-Gal IgE may therefore recognize B-antigen-containing material.

This creates a potential scenario:

  • Group O recipient plus α-Gal sensitization leads to
  • Group B/AB plasma or platelets results in
  • Exposure to B antigen triggers
  • Cross-reactive anti-α-Gal IgE causes
  • Mast-cell/basophil activation induces
  • Allergic reaction which leads to potentially anaphylaxis

Why is this important for transfusion medicine?

ABO compatibility of plasma and platelets is often more complex than simply asking whether the component is ՛compatible.՛

Group O patients may receive Group B or AB plasma-containing components, particularly during emergencies, inventory constraints, or platelet transfusion where ABO-identical products are unavailable.

Recent multicenter epidemiologic data involving 558,823 platelet and plasma transfusions found a significantly higher rate of allergic transfusion reactions among Group O patients receiving B/AB components in US regions with high alpha-gal prevalence.

For Group O recipients receiving B or AB components in these high-prevalence regions, the overall risk ratio for allergic reactions was 3.93 compared with Group O components.

Interestingly, this signal was not detected outside the United States, highlighting how geography and the prevalence of alpha-gal sensitization may influence risk.

What should transfusion services take away?

  • Recognizing a history of alpha-gal syndrome
  • Considering TRAGS in unexplained or unusually severe allergic/anaphylactic transfusion reactions
  • Reviewing the ABO group of the recipient and transfused plasma-containing component
  • Considering regional prevalence of alpha-gal sensitization
  • Documenting suspected cases carefully for future transfusion planning
  • Developing risk-based strategies rather than blanket restrictions

Transfusion compatibility is not always just:

ABO – Rh – antibody screen – crossmatch․

The biology of the recipient, donor plasma, glycan structures, environmental exposures and regional epidemiology can intersect in unexpected ways.”

Title: Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome

Authors: Richard M. Kaufman, Anne G. Hoen, Jenna Khan, C. Michael Knudson, Ryan A. Metcalf, Andres E. Mindiola Romero, Allison Mo, Richard Schäfer, Minoko Takanashi, Nancy M. Dunbar

Neeraj Songara։ TRAGS - When Alpha-Gal Meets ABO Compatibility

Stay updated with Hemostasis Today.

ABO Allison Mo Alpha-Gal Andres E. Mindiola Romero Anne G. Hoen C. Michael Knudson Health Hematology Hemostasis Hemostasis News Hemostasis Today JAMA Internal Medicine Jenna Khan Medicine Minoko Takanashi Nancy M. Dunbar Neeraj Songara Richard M. Kaufman Richard Schäfer Ryan A. Metcalf
NewsFeed